SigmaAldrich fundamentals

Use SigmaAldrich Corporation fundamentals together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio

SigmaAldrich Corporation is rated second in price to sales category among related companies. It is rated third in retained earnings category among related companies reporting about  1,223,495,702  of Retained Earnings per Price to Sales.

Price to Sales ( times )

Return On Equity Return On Asset Profit Margin Operating Margin Current Valuation Shares Outstanding Shares Owned by Insiders Shares Owned by Institutions Number of Shares Shorted Price to Earning Price to Book Price to Sales Revenue Gross Profit EBITDA Net Income Cash and Equivalents Cash per Share Total Debt Debt to Equity Current Ratio Book Value Per Share Cash Flow from Operations Short Ratio One Year High One Year Low Earnings Per Share Price to Earnings To Growth Number of Employees Beta Market Capitalization Total Asset Retained Earnings Working Capital Current Asset Current Liabilities Z Score Probability Of Bankruptcy

SigmaAldrich competes with WILLIAMS, P P, SHERWIN, VALSPAR, and INTL. Its chemical solutions and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. SigmaAldrich Corporation sells its solutions to commercial laboratories, pharmaceutical companies, industrial companies, universities, diagnostics companies, biotechnology companies, electronics companies, hospitals, governmental institutions, and nonprofit organizations. SigmaAldrich Corporationration was founded in 1951 and is based in St. Louis, Missouri.